Merck expands with new filtration production lines at Peenya facility in BengaluruIllustrative image – not actual.

Merck, a leading global science and technology company, has announced the expansion of its manufacturing facility in Peenya, Bengaluru.

The investment will introduce new production lines for filtration hardware systems in 2025, followed by the production of Pellicon 2 Ultrafiltration Cassettes in 2026. It is widely recognised as a reliable solution for high-quality purification processes, serving diverse applications in biopharmaceutical manufacturing and research. The Peenya facility has been an important hub for Merck’s global filtration hardware production since 2006 and began producing consumable products, including prefilter cartridges, in 2022. With this latest expansion, Merck aims to further integrate India into its global manufacturing and supply chain network.

The initiative also aligns with the Government of India’s “Make in India” vision, strengthening domestic advanced manufacturing capabilities. “These products are essential to producing life-saving medicines and vaccines,” said Tony Qiu, Head of APAC Operations, Life Science Business of Merck. “By expanding manufacturing in India, the company is strengthening global supply chains while supporting local innovation and skills," he said.

← All latest storiesBack to top →